Revised North Star Ambulatory Assessment for Young Boys with Duchenne Muscular Dystrophy

Area of Science:

• Pediatrics
• Neurology
• Genetics

Background:

• Therapeutic advancements for Duchenne muscular dystrophy (DMD) necessitate reliable outcome measures for early diagnosis and monitoring.
• Assessing functional abilities in young children with DMD is crucial for understanding disease progression and treatment response.

Purpose of the Study:

• To develop a revised North Star Ambulatory Assessment (NSAA) scale tailored for boys aged 3-5 years.
• To identify age-appropriate items and adapt the scoring system for early detection of functional deficits in DMD.

Main Methods:

• The revised NSAA was validated using data from 171 typically developing children aged 2.9 to 4.8 years.
• Items were deemed age-appropriate if mastered by at least 85% of controls at specific ages.
• The scale was reordered based on age-specific item mastery.

Main Results:

• At 3 years, only 8 NSAA items were age-appropriate; by 4 years, all 17 items were mastered by controls.
• The revised scale demonstrated that most young DMD boys struggled to achieve age-appropriate scores.
• The study identified significant delays in skill acquisition among young DMD patients compared to peers.

Conclusions:

• A revised NSAA provides a valuable tool for assessing functional abilities in young boys with Duchenne muscular dystrophy from age 3.
• This assessment aids in understanding the acquisition of new abilities and their correlation with peer development in DMD.
• The revised NSAA supports early intervention strategies and monitoring of therapeutic efficacy in pediatric DMD.